2013
DOI: 10.4161/hv.27057
|View full text |Cite
|
Sign up to set email alerts
|

Lipid core peptide targeting the cathepsin D hemoglobinase ofSchistosoma mansonias a component of a schistosomiasis vaccine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(25 citation statements)
references
References 47 publications
(75 reference statements)
0
25
0
Order By: Relevance
“…antischistosomal vaccines based on recombinant schistosomal APDs (Table 1) [56,57]. However, it has been proposed that helminth vaccines should be based on at least two parasite enzymes involved in different processes, for example hemoglobin digestion and larval maturation [58].…”
Section: Parasite Apds As Therapeutic Targetsmentioning
confidence: 99%
“…antischistosomal vaccines based on recombinant schistosomal APDs (Table 1) [56,57]. However, it has been proposed that helminth vaccines should be based on at least two parasite enzymes involved in different processes, for example hemoglobin digestion and larval maturation [58].…”
Section: Parasite Apds As Therapeutic Targetsmentioning
confidence: 99%
“…lysine) and lipoamino acid into one molecule. LCP has been extensively used as a peptide-based vaccine delivery system and showed high efficacy to stimulate immune responses against hookworm [19,20], malaria [21], Schistosoma [20,22] and cancer [23]. While the majority of reported LCP conjugates induced strong systemic responses, only lipopeptide 1 (Figure 1) was able to induce mucosal immunity [24].…”
Section: Introductionmentioning
confidence: 99%
“…This result indicated the importance of epitope conformation for peptide subunit vaccine development. Importantly, both series of vaccine candidates that targeted hookworm and Schistosoma did not induce any hemolytic effect and were not toxic in vitro even at a high concentration (100 μM) [95,97].…”
Section: Lipid-based Self-assembled Nanostructurementioning
confidence: 98%
“…Moreover, the lipidic moiety in LCP is recognized by TLR2, thus has self-adjuvanting properties [91], is preferentially taken up by APCs, and induced strong immune responses against the incorporated antigens [92,93]. For example, Fuaad et al synthesized an LCP-based vaccine candidate against schistosomiasis carrying an epitope (p2, KQAEDKVKAGPTDEIQKINAKQLEDKVK) derived from cathepsin D hemoglobinase [94,95]. The conjugate self-assembled into nanoparticles with diameters of 30-80 nm.…”
Section: Lipid-based Self-assembled Nanostructurementioning
confidence: 99%